Mitsubishi Tanabe raises forecast despite weak first quarter
This article was originally published in Scrip
Executive Summary
Mitsubishi Tanabe Pharma (MTP) has raised its sales and profit guidance for the remainder of the fiscal year despite a lacklustre first three months.